These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
272 related articles for article (PubMed ID: 3546575)
1. Use of insertional inactivation to facilitate studies of biological properties of pneumococcal surface protein A (PspA). McDaniel LS; Yother J; Vijayakumar M; McGarry L; Guild WR; Briles DE J Exp Med; 1987 Feb; 165(2):381-94. PubMed ID: 3546575 [TBL] [Abstract][Full Text] [Related]
2. Role of pneumococcal surface protein A in the virulence of Streptococcus pneumoniae. Briles DE; Yother J; McDaniel LS Rev Infect Dis; 1988; 10 Suppl 2():S372-4. PubMed ID: 3187321 [TBL] [Abstract][Full Text] [Related]
3. PspA family fusion proteins delivered by attenuated Salmonella enterica serovar Typhimurium extend and enhance protection against Streptococcus pneumoniae. Xin W; Li Y; Mo H; Roland KL; Curtiss R Infect Immun; 2009 Oct; 77(10):4518-28. PubMed ID: 19687204 [TBL] [Abstract][Full Text] [Related]
4. Protective humoral response against pneumococcal infection in mice elicited by recombinant bacille Calmette-Guérin vaccines expressing pneumococcal surface protein A. Langermann S; Palaszynski SR; Burlein JE; Koenig S; Hanson MS; Briles DE; Stover CK J Exp Med; 1994 Dec; 180(6):2277-86. PubMed ID: 7964500 [TBL] [Abstract][Full Text] [Related]
5. A live recombinant avirulent oral Salmonella vaccine expressing pneumococcal surface protein A induces protective responses against Streptococcus pneumoniae. Nayak AR; Tinge SA; Tart RC; McDaniel LS; Briles DE; Curtiss R Infect Immun; 1998 Aug; 66(8):3744-51. PubMed ID: 9673257 [TBL] [Abstract][Full Text] [Related]
6. Truncated Streptococcus pneumoniae PspA molecules elicit cross-protective immunity against pneumococcal challenge in mice. Tart RC; McDaniel LS; Ralph BA; Briles DE J Infect Dis; 1996 Feb; 173(2):380-6. PubMed ID: 8568299 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of a vaccine formulation against Streptococcus pneumoniae based on choline-binding proteins. Miyaji EN; Vadesilho CF; Oliveira ML; Zelanis A; Briles DE; Ho PL Clin Vaccine Immunol; 2015 Feb; 22(2):213-20. PubMed ID: 25520146 [TBL] [Abstract][Full Text] [Related]
8. Relationship between surface accessibility for PpmA, PsaA, and PspA and antibody-mediated immunity to systemic infection by Streptococcus pneumoniae. Gor DO; Ding X; Briles DE; Jacobs MR; Greenspan NS Infect Immun; 2005 Mar; 73(3):1304-12. PubMed ID: 15731027 [TBL] [Abstract][Full Text] [Related]
9. Localization of protection-eliciting epitopes on PspA of Streptococcus pneumoniae between amino acid residues 192 and 260. McDaniel LS; Ralph BA; McDaniel DO; Briles DE Microb Pathog; 1994 Nov; 17(5):323-37. PubMed ID: 7723659 [TBL] [Abstract][Full Text] [Related]
10. Genetic immunization with the region encoding the alpha-helical domain of PspA elicits protective immunity against Streptococcus pneumoniae. Bosarge JR; Watt JM; McDaniel DO; Swiatlo E; McDaniel LS Infect Immun; 2001 Sep; 69(9):5456-63. PubMed ID: 11500417 [TBL] [Abstract][Full Text] [Related]
11. Protective Immune Responses Elicited by Fusion Protein Containing PsaA and PspA Fragments. Lu J; Sun T; Wang D; Dong Y; Xu M; Hou H; Kong FT; Liang C; Gu T; Chen P; Sun S; Lv X; Jiang C; Kong W; Wu Y Immunol Invest; 2015; 44(5):482-96. PubMed ID: 26107747 [TBL] [Abstract][Full Text] [Related]
12. PspA, a surface protein of Streptococcus pneumoniae, is capable of eliciting protection against pneumococci of more than one capsular type. McDaniel LS; Sheffield JS; Delucchi P; Briles DE Infect Immun; 1991 Jan; 59(1):222-8. PubMed ID: 1987036 [TBL] [Abstract][Full Text] [Related]
13. Comparison of the PspA sequence from Streptococcus pneumoniae EF5668 to the previously identified PspA sequence from strain Rx1 and ability of PspA from EF5668 to elicit protection against pneumococci of different capsular types. McDaniel LS; McDaniel DO; Hollingshead SK; Briles DE Infect Immun; 1998 Oct; 66(10):4748-54. PubMed ID: 9746574 [TBL] [Abstract][Full Text] [Related]
14. Enhanced protective immunity against pneumococcal infection with PspA DNA and protein. Moore QC; Bosarge JR; Quin LR; McDaniel LS Vaccine; 2006 Jul; 24(29-30):5755-61. PubMed ID: 16759765 [TBL] [Abstract][Full Text] [Related]
15. Pneumococcal surface protein A (PspA) is serologically highly variable and is expressed by all clinically important capsular serotypes of Streptococcus pneumoniae. Crain MJ; Waltman WD; Turner JS; Yother J; Talkington DF; McDaniel LS; Gray BM; Briles DE Infect Immun; 1990 Oct; 58(10):3293-9. PubMed ID: 1698178 [TBL] [Abstract][Full Text] [Related]
16. Relative roles of genetic background and variation in PspA in the ability of antibodies to PspA to protect against capsular type 3 and 4 strains of Streptococcus pneumoniae. Roche H; Ren B; McDaniel LS; Håkansson A; Briles DE Infect Immun; 2003 Aug; 71(8):4498-505. PubMed ID: 12874329 [TBL] [Abstract][Full Text] [Related]
17. The virulence function of Streptococcus pneumoniae surface protein A involves inhibition of complement activation and impairment of complement receptor-mediated protection. Ren B; McCrory MA; Pass C; Bullard DC; Ballantyne CM; Xu Y; Briles DE; Szalai AJ J Immunol; 2004 Dec; 173(12):7506-12. PubMed ID: 15585877 [TBL] [Abstract][Full Text] [Related]
18. The genetic background of Streptococcus pneumoniae affects protection in mice immunized with PspA. He X; McDaniel LS FEMS Microbiol Lett; 2007 Apr; 269(2):189-95. PubMed ID: 17355599 [TBL] [Abstract][Full Text] [Related]
19. Monoclonal antibodies against protease-sensitive pneumococcal antigens can protect mice from fatal infection with Streptococcus pneumoniae. McDaniel LS; Scott G; Kearney JF; Briles DE J Exp Med; 1984 Aug; 160(2):386-97. PubMed ID: 6381634 [TBL] [Abstract][Full Text] [Related]